Antimicrobial resistance (AMR) is in the news lately and for good reason. Diseases that were once easy to treat are becoming increasingly difficult to cure. But the largest contributor to AMR is a disease that rarely makes headlines – drug-resistant tuberculosis (DR-TB), the world’s only airborne drug-resistant infection. DR-TB makes up a third of the [….]
Representatives from Johnson & Johnson Innovation will provide an overview of goals and mission, highlighting how Johnson & Johnson Innovation interacts with the entrepreneurial community through JLABS, JJDC, The Innovation Centers and Janssen Business & Development.
Self Serve Lab Consumables Now Available for Startups at JHU’s FastForward with New Thermo Fisher Scientific Partnership
FastForward JHU Incubator
JHU Tech Ventures FastForward 1812